Stein Klaus-Peter, Wanke Isabel, Schlamann Marc, Dammann Philipp, Moldovan Alexia-Sabine, Zhu Yuan, Sure Ulrich, Sandalcioglu I Erol
Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen, Hufelandstrasse 55, 45122, Essen, Germany,
Neurosurg Rev. 2014 Oct;37(4):619-28. doi: 10.1007/s10143-014-0551-9. Epub 2014 May 9.
The present study aimed to determine the clinical presentation, the multimodal interdisciplinary treatment strategies and outcome of posterior fossa arterio-venous malformations (AVMs) in our neurovascular centre. Fifty-three patients with a posterior fossa AVM were seen between 1998 and 2012 and analysed retrospectively. Patients were either managed conservatively or treated with endovascular, microsurgical or radiosurgical procedures or in combination. Thirty-nine patients (74 %) presented with intracranial haemorrhage and 14 patients (26 %) with unspecific symptoms. In 22 cases with haemorrhage (56 %), an intracerebellar haematoma was found, whereas 17 patients (44 %) suffered from subarachnoid haemorrhage. AVMs were located in the cerebellum in 44 patients (83 %), in the brainstem in four patients (7.5 %) and the cerebello-pontine angle in another four individuals (7.5 %). Forty-two patients (79 %) were treated either by emboliziation (n = 12, 29 %), surgical resection (n = 16, 38 %), surgical resection with preoperative embolization (n = 12, 29 %) or radiotherapy alone (n = 2, 4 %). A total of eleven patients did not receive any treatment (21 %). Both, morbidity and mortality related to treatment were 12 %, whereas overall morbidity and mortality was 26 and 15 %, respectively. Complete AVM elimination was achieved in 81 % of the treated lesions. A multimodal treatment sequence nowadays represents the gold standard for posterior fossa AVMs. Patients are at high risk for morbidity and mortality, due to the impact of haemorrhage and treatment. Therefore, treatment has to be thoroughly indicated, especially for those patients without bleeding. The initial neurological condition seems to be crucial in terms of clinical outcome.
本研究旨在确定我们神经血管中心后颅窝动静脉畸形(AVM)的临床表现、多模式跨学科治疗策略及治疗结果。1998年至2012年间共诊治53例后颅窝AVM患者,并进行回顾性分析。患者接受保守治疗或采用血管内、显微外科或放射外科手术治疗,或联合治疗。39例患者(74%)表现为颅内出血,14例患者(26%)表现为非特异性症状。22例出血患者(56%)发现小脑内血肿,17例患者(44%)发生蛛网膜下腔出血。44例患者(83%)的AVM位于小脑,4例患者(7.5%)位于脑干,另外4例患者(7.5%)位于小脑脑桥角。42例患者(79%)接受了栓塞治疗(n = 12,29%)、手术切除(n = 16,38%)、术前栓塞联合手术切除(n = 12,29%)或单纯放疗(n = 2,4%)。共有11例患者未接受任何治疗(21%)。与治疗相关的发病率和死亡率均为12%,而总体发病率和死亡率分别为26%和15%。81%的治疗病变实现了AVM完全消除。如今,多模式治疗方案是后颅窝AVM的金标准。由于出血和治疗的影响,患者有较高的发病和死亡风险。因此,必须充分权衡治疗指征,尤其是对于那些未出血的患者。初始神经状况似乎对临床结果至关重要。